Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibrin scaffold formation refers to the assembly of a three-dimensional fibrin matrix, a naturally occurring biopolymer network created by the polymerization of fibrinogen and thrombin during blood coagulation. This process is essential in physiological wound healing, where the matrix acts as both a hemostatic plug and a provisional extracellular matrix guiding cell infiltration and tissue repair[2][3][6]. Engineered fibrin scaffolds are widely used in tissue engineering and regenerative medicine owing to their biocompatibility, biodegradability, and ability to support cell migration, proliferation, and differentiation. The structure and properties of these scaffolds—such as porosity, mechanical strength, and degradation rate—can be tuned by altering the concentration of fibrin(ogen), thrombin, or adding crosslinkers like genipin or factor XIIIa[1][2][3]. Their applications span skin, nerve, bone repair, and as carriers for drug or cell delivery[2][6][7]. Fibrin scaffolds have limitations, including rapid in vivo degradation and potential immunogenicity depending on the source material, but hybrid or chemically modified forms are being developed to address these challenges[2][4]. As a target, "fibrin matrix/scaffold formation" is not a conventional molecular target (e.g., enzyme, receptor), but rather a biomaterial modality used in therapeutic strategies.
Scaffold acts as a physical matrix for cell attachment, migration, proliferation, and differentiation[2][3][6]. Used as a drug and cell delivery system in regenerative medicine and surgery[6][7]. Mimics the extracellular matrix to support tissue repair and regeneration[2][3][7].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibrin scaffold formation.